American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth 
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations 
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
The Maire - EuroChem Case: Three Lessons for Global Business 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push 
DENVER, May 24, 2017 -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen M. Deitsch, Senior Vice President, Chief Financial Officer and Treasurer will present at the Jefferies 2017 Global Healthcare Conference on Wednesday, June 7, 2017, at 4:00 p.m. EDT.
A live webcast of the presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://www.bioscrip.com/investors or through the following link http://wsw.com/webcast/jeff105/bios.
About BioScrip
BioScrip, Inc. is a leading national provider of infusion and home care management solutions. BioScrip partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Investor Contacts: Stephen Deitsch Chief Financial Officer & Treasurer T: (720) 697-5200 [email protected] David Clair ICR, Inc. T: (646) 277-1266 [email protected]
